02/02/2007
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
ReGen Therapeutics Plc
2. Reason for the notification:
An acquisition or disposal of voting rights
3. Full name of person(s) subject to the notification obligation (iii):
Barclays PLC
4. Full name of shareholder(s) (if difference from 3):
Barclays Stockbrokers Ltd
Gerrard Ltd
5. Date of the transaction and date on which the threshold is crossed or reached (v):
24 January 2007
6. Date on which issued notified:
1 February 2007
7. Threshold(s) that is/are crossed or reached:
6%
8. Notified details
A: Voting rights attached to shares
Class/type of share if possible using the ISIN Code GB0004468319
Situation Previous to the triggering transaction (vi) -
Number of Shares 41,468,724
Number of Voting Rights (viii) 41,468,724
Resulting situation after the triggering transaction (viii) -
Number of Shares 41,868,724
Number of Voting Rights – Direct (x) N/A
Number of Voting Rights – Indirect (xi) 41,868,724
% of voting rights – Direct N/A
% of voting rights – Indirect 6.03
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of financial instrument N/A
Expiration date (xiii) N/A
Exercise/Conversion Period/Date (xiv) N/A
Number of voting rights that may be acquired if the
instrument is exercised/converted N/A
% of voting rights N/A
Total (A+B)
Number of voting rights 41,868,724
% of voting rights 6.03
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable (xv):
Barclays Stockbrokers Ltd
Gerrard Ltd
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information: N/A
14. Contact name: N/A
15. Contact telephone number: N/A
N/A
For further information:
Andrew Marshall
Greycoat Communications
Tel: +44 (0) 207 960 6007
Mobile: +44 (0) 7785 297111
Imran Ahmad / Rod Venables/ Cecil Jordaan
HB-Corporate
Tel: +44(0) 207 510 8600